Literature DB >> 19144360

Leigh-like syndrome with the T8993G mutation in the mitochondrial ATPase 6 gene: long-term follow-up discloses a slowly progressive course.

Cláudia Sobreira1, Wilson Marques, Octávio M Pontes Neto, Antônio Carlos Santos, João M Pina Neto, Amilton A Barreira.   

Abstract

We describe the long-term clinical outcome of a patient with Leigh-like syndrome presenting as an early onset encephalopathy and peripheral neuropathy caused by the T8993G mutation in the mitochondrial DNA (mtDNA). Clinical follow-up for 20 years revealed a peculiar pattern of slow disease progression, characterized by the addition of new minor deficits, while worsening of previous symptoms was mild. Brain MRI revealed cerebellar atrophy, diffuse demyelination of corona radiata and parietal white matter, and bilateral and symmetrical putaminal lesions. The proportion of mutant mtDNAs in blood was 72% (+/-0.02%) and in skeletal muscle was 81% (+/-0.4%). Leigh-like syndrome caused by the T8993G mtDNA mutation is a progressive disease, although not necessarily associated with an aggressive clinical course.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144360     DOI: 10.1016/j.jns.2008.11.023

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  A meta-analysis and systematic review of Leigh syndrome: clinical manifestations, respiratory chain enzyme complex deficiency, and gene mutations.

Authors:  Xueli Chang; Yaxin Wu; Jie Zhou; Huaxing Meng; Wei Zhang; Junhong Guo
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

2.  NARP Syndrome: A 20-Year Follow-Up.

Authors:  Mark J Rawle; A J Larner
Journal:  Case Rep Neurol       Date:  2013-12-19

3.  Leigh Syndrome in Childhood: Neurologic Progression and Functional Outcome.

Authors:  Jin Sook Lee; Hunmin Kim; Byung Chan Lim; Hee Hwang; Jieun Choi; Ki Joong Kim; Yong Seung Hwang; Jong Hee Chae
Journal:  J Clin Neurol       Date:  2016-04       Impact factor: 3.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.